... pre-Oscar party in Beverly Hills. In the US, approximately 75% of adults are overweight. Popular medications like Ozempic and Munjaro have already flooded the market, but it seems they haven't solved the problem. And prices remain high, even though Donald #Trump secured price reductions from Eli Lilly and Novo Nordisk. Sejaro's manufacturer has not commented on the situation. So, one can only guess whether this is a well-thought-out marketing ploy or the Russian drug's first foray into th...
...e American market. |